Canada Pension Plan Investment Board led a $400m Series C round in insitro, a machine learning-driven drug discovery and development company, with participation from Andreessen Horowitz, T. Rowe Price Associates, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital and Alexandria Venture Investments. Proceeds from the financing will be used to further expand insitro’s platform capabilities and pipeline, providing resources to access enabling datasets, enabling or complementary technologies and platforms, and potential in-licensed assets that have been de-risked by the company’s unique approach to target and patient biomarker discovery.